Skip to content

    Hepatitis Health Center

    Font Size
    A
    A
    A

    Longer Hepatitis C Treatment Best

    Cure Rates Are Higher With Longer Treatment of 6 Months
    By
    WebMD Health News
    Reviewed by Louise Chang, MD

    July 11, 2007 -- Shortening treatment to less than six months does not appear to be a good strategy for patients with the most curable types of hepatitis C virus infection, new research suggests.

    Patients with hepatitis C genotypes 2 and 3 who were treated for four months had lower cure rates and higher relapse rates than those treated for six months.

    The study, which appears in tomorrow’s New England Journal of Medicine, shows that longer treatment benefits even those with highly treatable hepatitis C, researcher Mitchell L. Shiffman, MD, tells WebMD.

    “I tell patients if they can tolerate treatment and can stay on it for 24 weeks, they have a better chance of achieving the best possible outcome, which is a cure,” he says.

    Hepatitis C Treatment Strategies

    Long-term infection with hepatitis C virus (HCV) is a leading cause of cirrhosis, liver cancer, and liver transplants in the United States. As many as 4 million Americans are infected, but most don’t know it, experts say.

    About 70% of infected Americans carry the genotype 1 form of hepatitis C, which tends to be less responsive to treatment than genotypes 2 and 3.

    With aggressive treatment, nearly 80% of people with genotypes 2 or 3 achieve complete and sustained viral eradication, or cures, compared with about 40% to 45% of people carrying genotype 1 virus.

    These days, most patients are treated with a long-acting version of the injected drug interferon along with the antiviral drug ribavirin.

    The standard course of treatment for patients with the more treatable types of hepatitis C infection is half that of patients with genotype 1 hepatitis C -- 24 weeks compared with 48 weeks.

    In several recent studies, it was reported that shortening treatment to four months and even three months had no impact on cure rates in hepatitis C genotype 2 or 3 patients.

    In an effort to test these findings, Shiffman and colleagues from Virginia Commonwealth University compared outcomes among genotype 2 or 3 patients treated for four months and six months.

    They report that 31% of patients treated with the shorter course of therapy eventually relapsed, compared with 18% of patients who got the full six months of treatment. Relapse was defined as having detectable levels of virus in the blood at follow-up despite complete viral eradication at the end of treatment.

    Overall, 62% of patients treated for four months achieved sustained viral responses, compared with 70% of patients treated for six months.

    Among patients who achieved complete viral responses within a month of starting treatment, 79% of those treated for four months achieved complete, sustained responses, compared to 85% of the patients treated for six months.

    Today on WebMD

    Hepatitus C virus
    Types, symptoms and treatments.
    liver illustration
    Myths and facts about this essential organ.
     
    woman eating apple
    What you need to know.
    doctor and patient
    What causes it?
     
    Hepatitis C Treatment
    Article
    Syringes and graph illustration
    Tool
     
    liver illustration
    Quiz
    passport, pills and vaccine
    Slideshow
     
    Scientist looking in microscope
    Slideshow
    Fatty Liver Disease
    Article
     
    Digestive Diseases Liver Transplantation
    Article
    Picture Of The Liver
    Image Collection